Lmr Partners LLP Sarepta Therapeutics, Inc. Transaction History

Lmr Partners LLP

$10.5 Billion
Q2 2025

A detailed history of Lmr Partners LLP transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Lmr Partners LLP holds 75,800 shares of SRPT stock, worth $1.77 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

75,800

Holding current value

$1.77 Million

% of portfolio

0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$104.54 - $137.94 $4.38 Million - $5.78 Million	-41,903 Reduced 91.84%	3,724 $452,000
Q3 2024 Nov 07, 2024	SELL	$124.33 - $156.75 $1.89 Million - $2.39 Million	-15,217 Reduced 25.01%	45,627 $5.7 Million
Q2 2024 Aug 14, 2024	BUY	$113.33 - $163.85 $6.9 Million - $9.97 Million	60,844 New	60,844 $9.61 Million
Q4 2023 Feb 14, 2024	BUY	$67.31 - $124.76 $1.52 Million - $2.83 Million	22,654 New	22,654 $2.18 Million
Q1 2023 May 15, 2023	BUY	$117.53 - $155.99 $2.98 Million - $3.96 Million	25,389 Added 133.0%	44,479 $6.13 Million
Q4 2022 Feb 14, 2023	SELL	$100.86 - $132.13 $448,726 - $587,846	-4,449 Reduced 18.9%	19,090 $2.47 Million
Q3 2022 Nov 14, 2022	SELL	$75.71 - $119.24 $6.82 Million - $10.7 Million	-90,121 Reduced 79.29%	23,539 $2.6 Million
Q2 2022 Aug 15, 2022	BUY	$62.69 - $88.44 $3.25 Million - $4.59 Million	51,901 Added 84.04%	113,660 $8.52 Million
Q1 2022 May 16, 2022	BUY	$63.15 - $90.42 $3.9 Million - $5.58 Million	61,759 New	61,759 $4.83 Million
Q3 2021 Nov 15, 2021	SELL	$65.97 - $92.48 $395,622 - $554,602	-5,997 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$69.38 - $86.75 $416,071 - $520,239	5,997 New	5,997 $466,000
Q1 2021 May 17, 2021	SELL	$72.25 - $168.95 $3.76 Million - $8.78 Million	-51,986 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$125.56 - $178.74 $6.53 Million - $9.29 Million	51,986 New	51,986 $8.86 Million
Q3 2019 Nov 14, 2019	SELL	$72.81 - $156.91 $1.41 Million - $3.04 Million	-19,359 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$112.21 - $151.95 $815,430 - $1.1 Million	-7,267 Reduced 27.29%	19,359 $2.94 Million
Q1 2019 May 15, 2019	BUY	$106.67 - $151.68 $2.84 Million - $4.04 Million	26,626 New	26,626 $3.17 Million
Q4 2018 Feb 14, 2019	SELL	$97.32 - $148.76 $3.62 Million - $5.54 Million	-37,216 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$115.31 - $161.51 $6.91 Million - $9.68 Million	-59,929 Reduced 61.69%	37,216 $6.01 Million
Q2 2018 Aug 03, 2018	BUY	$71.74 - $153.69 $6.97 Million - $14.9 Million	97,145 New	97,145 $12.8 Million

Others Institutions Holding SRPT

# of Institutions

456

Shares Held

82.3M

Call Options Held

5.6M

Put Options Held

4.19M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $2.04B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Lmr Partners LLP with notifications on news.

Account